Abstract
The Efficacy and Safety of the Combination Therapy of Decitabine, Venetoclax, and Selinexor (DVS) for Newly Diagnosed Unfit AML and MDS, and Relapsed/ Refractory AML and High-Risk MDS - a Multicenter, Single Arm, Prospective Clinical Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have